Detalhe da pesquisa
1.
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping.
Ann Rheum Dis
; 83(2): 242-252, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903543
2.
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study.
Ann Rheum Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423757
3.
Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort.
Rheumatology (Oxford)
; 63(4): 1022-1029, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379132
4.
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.
Rheumatology (Oxford)
; 63(2): 525-533, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208196
5.
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
J Rheumatol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490668
6.
Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice.
Lupus
; : 9612033241247908, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622764
7.
Demographic Traits, Clinical Status, and Comorbidities of Patients With Thromboangiitis Obliterans in Japan.
Circ J
; 88(3): 319-328, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423757
8.
Organ Damage and Quality of Life in Takayasu Arteritisã- Evidence From a National Registry Analysis.
Circ J
; 88(3): 285-294, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123296
9.
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Mod Rheumatol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445746
10.
Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database.
Mod Rheumatol
; 34(2): 287-296, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039670
11.
The real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web-questionnaire survey.
Mod Rheumatol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38590042
12.
Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020.
Mod Rheumatol
; 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343272
13.
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.
Mod Rheumatol
; 34(2): 322-328, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786480
14.
Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.
Mod Rheumatol
; 34(2): 382-390, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988333
15.
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.
Mod Rheumatol
; 34(3): 551-558, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279574
16.
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
Mod Rheumatol
; 34(3): 559-567, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599461
17.
Establishing clinical remission criteria for giant cell arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis.
Mod Rheumatol
; 34(3): 568-575, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37225423
18.
Factors contributing to the improvement in J-HAQ after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).
Mod Rheumatol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727535
19.
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Mod Rheumatol
; 34(2): 272-286, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405710
20.
Consensus statement on the management of late-onset rheumatoid arthritis.
Mod Rheumatol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511322